Y-Intercept (HK)’s Corcept Therapeutics CORT Stock Holding History

Y-Intercept (HK)’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-35,901	Closed	-$2.98M	–	1615
2025 Q3	$2.98M	Buy	35,901 +15,033	+72%	+$1.09M	0.07%	407
2025 Q2	$1.53M	Buy	20,868 +11,881	+132%	+$861K	0.04%	727
2025 Q1	$1.03M	Sell	8,987 -33,031	-79%	-$2.01M	0.07%	398
2024 Q4	$2.12M	Buy	+42,018	New	+$2.2M	0.14%	194
2023 Q4	–	Sell	-7,765	Closed	-$212K	–	1282
2023 Q3	$212K	Buy	+7,765	New	+$225K	0.02%	897
2023 Q1	–	Sell	-11,139	Closed	-$226K	–	1229
2022 Q4	$226K	Buy	+11,139	New	+$279K	0.03%	781
2022 Q2	–	Sell	-11,782	Closed	-$265K	–	906
2022 Q1	$265K	Buy	+11,782	New	+$251K	0.06%	500

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Y-Intercept (HK)'s CORT Position: Q4 2025 in Review

Y-Intercept (HK) sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 35,901 shares — an estimated $2.98M sold.

Y-Intercept (HK) first reported a position in CORT in Q1 2022 and held it in 7 quarters. The position peaked at $2.98M in Q3 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

Y-Intercept (HK) reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
Y-Intercept (HK) sold 35,901 Corcept Therapeutics shares in Q4 2025, an estimated $2.98M.
Y-Intercept (HK) first reported a position in Corcept Therapeutics in Q1 2022 and held it in 7 quarters.
Y-Intercept (HK)'s Corcept Therapeutics position peaked at $2.98M in Q3 2025.
389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on Y-Intercept (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.